Immunicom’s new Vice President of Regulatory Affairs, Christian Shenouda M.D., has an expansive portfolio in efficient and expedited regulatory path...
JACKSON, Mich.--(BUSINESS WIRE)--Anesthesia Business Consultants (ABC), the leading provider of billing and practice management services for the anesthesia and pain...
NEW YORK--(BUSINESS WIRE)--$pavm--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
Ovaice brings over 20 years of extensive creative experience to this role leading creative outputs for the global Google account...
DALLAS, Oct. 7, 2021 /PRNewswire/ -- Integrity Marketing Group, LLC ("Integrity"), one of the largest independent distributors of life, health...
Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the mergerResults...
GOTHENBURG, SE / ACCESSWIRE / October 7, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Invitation to attend XVIVO's conference call...
JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing...
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology...
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent RestenosisREDWOOD CITY, CA / ACCESSWIRE / October 7,...
Research using Canadian technology by Cloud DX provides evidence healthcare decision-makers need; RPM improves patient outcomes and healthcare delivery.News in...
Helsinn Group announces oral presentation of data at AACR-NCI-EORTC relating to a potent and highly selective investigational RET inhibitor Lugano,...
Tumor shrinkage and partial responses observed in patients with advanced head and neck squamous cell carcinoma (HNSCC) treated with MCLA-158In...
MARKHAM, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced the...
Meeting, taking place October 7-10, 2021, is hosted by the American Association for Cancer Research (AACR), the National Cancer Institute...
– Lead oral PRMT5 inhibitors PRT543 and PRT811 demonstrate favorable safety profile, evidence of preliminary clinical activity including durable responses...
ARLINGTON, Va., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to...
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB), a commercial-stage biopharmaceutical...
First in human, multicenter, non-randomized, open-label trial has expanded to three sites and is actively recruitingSAN FRANCISCO and SAN DIEGO,...
SAN DIEGO, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...